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One-pot ortho-amination of aryl C–H bonds using
consecutive iron and copper catalysis†
Martyn C. Henry, Rochelle McGrory, Réka J. Faggyas, Mohamed A. B. Mostafa
and Andrew Sutherland *
A one-pot approach for ortho-coupling of arenes with non-actived N-nucleophiles has been developed
using sequential iron and copper catalysis. Regioselective ortho-activation of anisoles, anilines and
phenols was achieved through iron(III) triﬂimide catalysed iodination, followed by a copper(I)-catalysed,
ligand-assisted coupling reaction with N-heterocycle, amide and sulfonamide-based nucleophiles. The
synthetic utility of this one-pot, two-step method for the direct amination of ortho-aryl C–H bonds was
demonstrated with the late-stage functionalisation of 3,4-dihydroquinolin-2-ones. This allowed the
preparation of a TRIM24 bromodomain inhibitor and a series of novel analogues.
Introduction
In the last few decades, significant progress in the develop-
ment of transition metal catalysed reactions has resulted in
regioselective formation of aryl C–N bonds and the use of
these processes for the general synthesis of pharmaceutically
active compounds, organic materials and natural products.1
Early methods involved the copper- or palladium-catalysed
amination of aryl (pseudo)halides using Ullmann–Goldberg,
Chan–Evans–Lam or Buchwald–Hartwig methods (Fig. 1a).2,3
More recently, procedures have also been developed for the
amination of aryl halides using a combination of iron and
copper catalysis.4 While extensive reaction optimisation has
resulted in highly eﬃcient transformations, a drawback to this
approach is the requirement of pre-functionalised arenes.
To avoid arene ring pre-functionalisation, more recent strat-
egies have focused on ortho-directed dehydrogenative coupling
of aryl C–H bonds with non-activated amines and amides
using chelating auxiliary groups in the presence of oxidants
such as oxygen or hypervalent iodine compounds.5 This
method has found application for the regioselective substi-
tution of a wide range of arenes, including the ortho-amination
of anilines.5,6 For example, Rodríguez and co-workers
described the eﬃcient copper-catalysed amination of anilines
using the 2-picolinic acid directing group and (diacetoxyiodo)
benzene as the oxidant (Fig. 1b).7,8 The auxiliary group could
be removed under basic conditions to access the ortho-ami-
nated aniline in high overall yield. Mechanistically distinct,
palladium-catalysed ortho-amination of para-substituted ani-
lides with N-fluorobenzenesulfonimide (NFSI) has also been
described (Fig. 1c).9 In this transformation, it was proposed
that the in situ generated FPdN(SO2Ph)2 formed a dearoma-
tised spiro-cyclopalladium intermediate that underwent an
ortho-nucleophilic amination with benzenesulfonimide.
Fig. 1 Selected methods for ortho C–H aryl amination.
†Electronic supplementary information (ESI) available: 1H and 13C NMR spectra
for all compounds. See DOI: 10.1039/c9ob00712a
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Alternatively, with ortho-substituted anilides, this approach
enabled the preparation of para-benzenesulfonimide functio-
nalised arenes.
We recently reported a one-pot para-amination and amida-
tion of activated arenes using sequential iron and copper cata-
lysis.10 The process permitted the reaction of para-aryl C–H
bonds with non-activated amines and amides via iron(III)-trifli-
mide catalysed arene bromination, followed by a copper(I)-cata-
lysed coupling reaction. However, attempted ortho-amination
of para-substituted anilines using this one-pot, two-step
approach led to inseparable mixtures of the coupled product
and the aniline starting material. Further studies revealed this
was due to competing reduction of the bromide intermediate
during the relatively slow copper-catalysed Goldberg-type11
amination. As current methods for transition metal catalysed
ortho-amination of arenes requires either aryl ring pre-functio-
nalisation or the use of chelating auxiliary groups with strong
oxidising conditions and often precious metals, we were inter-
ested in overcoming the issues of the one-pot iron and copper
catalysed method for direct access to ortho-aminated arenes.
Herein, we describe a one-pot intermolecular ortho-amination
of arenes using an iron-catalysed iodination, followed by a
copper-catalysed, ligand-assisted coupling reaction (Fig. 1d).
As well as exploring the scope of this method for the ortho-
amination or amidation of anilines, anisoles and phenols, we
also describe the use of the procedure for the late-stage amida-
tion of quinolin-2-ones and the structural diversification of a
TRIM24 bromodomain inhibitor.
Results and discussion
The study began by the investigation of the one-pot ortho-
amination of para-aminobenzonitrile (1a) with pyrazole
(Table 1). Iron(III) chloride and the ionic liquid, [BMIM]NTf2
were used for the in situ formation of the super Lewis acid,
iron triflimide and the activation of N-bromosuccinimide
(NBS) for ortho-bromination of 1a (entry 1).10,12 Following
full conversion to the bromide (4 h), the copper(I)-catalysed
coupling reaction with pyrazole, using N,N′-dimethyl-
ethylenediamine (4) (DMEDA) as the copper-chelating ligand
was investigated. This gave a 2 : 1 mixture of coupled product
3a and reduced compound 1a.13,14 It was proposed that a more
reactive aryl halide bond may facilitate the coupling reaction
over the reduction pathway. Therefore, the process was
repeated using N-iodosuccinimide (NIS) during the halogena-
tion step (entries 2 and 3). While this initially resulted in only
a modest improvement (entry 2), the combination of using a
lower reaction temperature (130 °C) during the coupling step
gave a 6 : 1 ratio of 3a and 1a (entry 3). To further refine the
process, alternative ligands were considered.15 Problems
associated with challenging Goldberg-type coupling reactions
are generally due to catalyst deactivation via competitive
N-arylation of the ligand.16 To overcome this issue, ligands
such as diketone 5 that exist in a delocalised enolate form and
are less likely to undergo arylation have been utilised. The use
of diketone 5 during the one-pot iodination and pyrazole coup-
ling of 1a did lead to coupled product 3a, but there was no
improvement in the product ratio (entry 4). On screening other
ligands that facilitate a wide range of N-arylation reactions,
racemic trans-N,N′-dimethylcyclohexane-1,2-diamine (6) gave
the highest selectivity of 12 : 1 for 3a versus 1a from the one-
pot process (entry 5).17 Further optimisation revealed that
increasing the amount of pyrazole led to complete suppression
of the reductive pathway and generation of only coupled
product 3a (entry 6). It should be noted that the involvement
of Fe3+ during the first step is crucial for the success of the
one-pot process. When iodination of 1a is performed under
the same conditions as in Table 1 (70 °C), but without the
presence of iron(III) chloride, only 40% conversion is observed
after 20 h.
Using the optimised conditions, the scope of the one-pot
ortho-amination of a range of activated para-substituted arenes
with pyrazole was explored (Scheme 1). Various anilines were
subjected to the standard one-pot iron-catalysed activation and
copper-catalysed coupling process and gave the ortho-substi-
tuted adducts (3a–3e) cleanly, in good yields (58–71%). This
method allows direct ortho-substitution of unprotected ani-
lines and despite the use of nucleophilic substrates, only
N-arylation by pyrazole was observed. Extension of the one-pot
process for the ortho N-arylation of anisoles, gave the corres-
ponding ortho-substituted compounds (3f–3k) in 48–71%
yield. Again, use of the highly regioselective iron-catalysed
mono-iodination reaction led to formation of the ortho-
Table 1 Optimisation of the one-pot ortho C–H amination process
Entry Pyrazole (equiv.) Ligand Temp. (°C) Ratio (3a : 1a)
1a 1.5 4 150 2 : 1
2 1.5 4 150 3 : 1
3 1.5 5 130 6 : 1
4 1.5 6 130 5 : 1
5 1.5 6 130 12 : 1
6 3 6 130 3a only
a The one-pot process was performed via the bromide intermediate
using NBS for the activation step.
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coupled adducts as the sole products, even using highly reac-
tive arenes with multiple activating groups (e.g. 1i, 1k).
A limitation of this method was found in the attempted
ortho-substitution of phenols (Scheme 1). Investigation of
p-cresol (1l) as a substrate for the one-pot process yielded less
than 20% of the coupled product with low conversion observed
for each step. We previously reported that iodination of
phenols could be improved using the softer Lewis acid, silver
triflimide to activate NIS.18 The use of silver triflimide
(7.5 mol%) was more eﬀective for ortho-iodination of p-cresol
(1l); however, the one-pot process yielded the coupled product
3l in a moderate 37% yield.
Using para-methylanisole (1f ), the scope of the nucleophile
was next explored (Scheme 1). With the standard one-pot
conditions for anisoles, various sulfonamides and amides
were smoothly coupled, allowing isolation of the ortho-sub-
stituted adducts (3m–3s) in good yields (52–78%). Using
weaker, less nucleophilic N-heterocycles such as imidazole
and pyrrole required a longer reaction time for the copper-
catalysed N-substitution step (36 h), but still gave the ortho-
substituted products 3t and 3u, cleanly. Two limitations
were found when examining the scope of the nucleophile for
the one-pot process. Electron-rich alkylamine nucleophiles
such as morpholine gave low conversion (<10%) to the
coupled product. The activity of the copper catalyst in these
processes is likely compromised by competitive binding
with the alkylamine nucleophiles, which are present in
significantly higher concentration than the diamine ligand.
Hindered heterocyclic nucleophiles such as 3,5-dimethyl-
pyrazole also gave no coupled product. In this case, coupling
at the ortho-position of an arene with an N-heterocyclic
nucleophile also bearing an adjacent substituent is too hin-
dered under these conditions for this transformation to
proceed.
A proposed mechanism for the one-pot, two-step process is
shown in Scheme 2. The combination of iron(III) chloride and
the [BMIM]NTf2 ionic liquid leads to the formation of the
super Lewis acid, Fe(NTf2)3 7.
19,20 The highly delocalised
nature of the triflimide counterion allows eﬀective activation
of NIS by Fe3+, resulting in rapid regioselective, electrophilic
aromatic iodination of the arene ring system. In the second
step, addition of copper(I) iodide and the chelating diamine
ligand, trans-N,N′-dimethylcyclohexane-1,2-diamine (6) results
in formation of 1,2-diamine-ligated copper(I) intermediate 8.
Mechanistic studies by the Buchwald and Hartwig groups have
shown subsequent reaction of copper(I) intermediate 8
with the base and nucleophile generates 1,2-diamine-ligated
copper(I) amidate 9.21 While radical and nonradical pathways
have been proposed for reaction of copper(I) amidate 9 with
haloarenes, the same mechanistic studies using experimental
tests for radical intermediates and DFT calculations have
shown that oxidative addition to 10 occurs without free aryl
radical intermediates.22 Despite this insight, the precise
mechanism of aryl halide activation is still not well-estab-
lished but Cu(III)-intermediates such as 10 are calculated to
be kinetically accessible by a concerted oxidative addition or
by internal electron transfer within the coordination sphere
of the metal.21a Fast reductive elimination of 10 then forms
the C–N coupled product and regenerates 1,2-diamine-ligated
copper(I) intermediate 8. As shown by the results above
(Scheme 1), the sequential transformations are highly compa-
tible within the one-pot halogenation–amination process,
leading to the clean formation of C–N coupled products. It
should also be noted that during the course of this study, by-
Scheme 1 One-pot ortho-amination and amidation of arenes.
a Iodination step was complete after 20 h. b Iodination step was done at
40 °C. c Iodination step was performed using AgNTf2 (7.5 mol%) at
40 °C. d The second step required 36 h.
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products due to an Ullmann-type, bi-aryl coupling were never
observed.
Having examined the scope and limitations of the one-pot
ortho-amination process, we wanted to demonstrate the syn-
thetic utility of this approach for the preparation of pharma-
ceutically relevant targets. Palmer and co-workers have shown
that sulfonamide substituted 3,4-dihydroquinolin-2-ones, such
as 16a (Scheme 3) are inhibitors of the bromodomain contain-
ing protein TRIM24, which is implicated in human cancers.23
It was proposed that use of the one-pot activation and ortho-
amidation process with N-methyl 3,4-dihydroquinoline-2-one
14 would allow rapid, late-stage access to 16a and a range of
novel analogues. 3,4-Dihydroquinolin-2-one 14 was prepared via
a two pot-process. Initially, 7-methoxy-3,4-dihydro-1H-quinolin-
2-one (13) was prepared via a one-pot multistep process, that
involved formation of the diazonium salt intermediate of
aniline 11 under mild conditions, followed by a base-free
Heck–Matsuda reaction with methyl acrylate to give cinnamate
intermediate 12.24 In the second part of the one-pot process,
re-utilisation of the palladium catalyst during a hydrogenation
reaction resulted in reduction and cyclisation to give 3,4-dihy-
droquinolin-2-one 13 in 79% overall yield. N-Methylation
under standard conditions then gave 14 in 92% yield.
Iodination of 14 was found to proceed with lower catalyst load-
ings of both iron(III) chloride (2.5 mol%) and [BMIM]NTf2
(7.5 mol%), under milder conditions (40 °C) than the general
process. In addition, despite the potential substitution of
either ortho-site, only iodination of the 6-position was observed
by 1H NMR analysis of the reaction mixture. Subsequent
copper(I)-catalysed coupling with benzenesulfonamide com-
pleted the one-pot transformation and gave TRIM24 inhibitor,
16a in 56% yield. Application of the one-pot ortho-amidation
of 14 for the late-stage synthesis of novel analogues of 16a was
then explored. Using other sulfonamides, benzamides and
heterocyclic nucleophiles gave coupled products 16b–16f in
good overall yields (51–61%). Overall, the utilisation of both
one-pot processes allowed rapid access to a range of novel
pharmaceutically relevant targets.
Scheme 2 Proposed one-pot Fe(III)- and Cu(I)-catalysed ortho-amida-
tion of 1f.
Scheme 3 Synthesis and late-stage functionalisation of 3,4-dihydro-
quinolin-2-one 14. a The second step required 72 h.
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Conclusions
In summary, a one-pot method for the ortho-amination and
amidation of arenes has been developed using sequential iron
and copper catalysis. Regioselective activation of arenes via
iodination, using NIS and the super Lewis acid, iron(III) trifli-
mide, followed by copper(I)-catalysed, ligand-assisted coupling
with a range of N-nucleophiles gave the ortho-substituted pro-
ducts in good yields. As well as allowing access to a range of
anisole adducts, this approach also permits direct ortho-amin-
ation of unprotected anilines, without the requirement of a
directing auxiliary group. The selective and mild nature of this
method was further demonstrated by the late-stage synthesis
of a quinolin-2-one inhibitor of the bromodomain containing
protein TRIM24, as well as a series of novel analogues. Further
applications of one-pot iron and copper-catalysed arene substi-
tution reactions are currently being investigated.
Experimental
All reagents and starting materials were obtained from com-
mercial sources and used as received. The synthesis of com-
pounds 13 24 and 14 25 were previously described in the litera-
ture. All dry solvents were purified using a solvent purification
system. All reactions were performed in oven-dried glassware
under an atmosphere of argon unless otherwise stated. Brine
refers to a saturated solution of sodium chloride. Flash
column chromatography was performed using silica gel 60
(40–63 μm) and neutral aluminium oxide (50–200 μm).
Aluminium-backed plates pre-coated with silica gel 60F254
were used for thin layer chromatography and were visualised
with a UV lamp or by staining with potassium permanganate.
1H NMR spectra were recorded on a NMR spectrometer at
either 400 or 500 MHz and data are reported as follows: chemi-
cal shift in ppm relative to tetramethylsilane or the solvent as
the internal standard (CDCl3, δ 7.26 ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet or
overlap of nonequivalent resonances, integration). 13C NMR
spectra were recorded on an NMR spectrometer at either 101
or 126 MHz and data are reported as follows: chemical shift in
ppm relative to tetramethylsilane or the solvent as internal
standard (CDCl3, δ 77.0 ppm), multiplicity with respect to
hydrogen (deduced from DEPT experiments, C, CH, CH2 or
CH3). IR spectra were recorded on a FTIR spectrometer; wave-
numbers are indicated in cm−1. Mass spectra were recorded
using electrospray or electron impact techniques. HRMS
spectra were recorded using a dual-focusing magnetic analyser
mass spectrometer. Melting points are uncorrected.
N-(2-Amino-5-cyanophenyl)-1H-pyrazole (3a)26
Iron(III) chloride (4.0 mg, 0.025 mmol) was dissolved in
1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)
imide (22 µL, 0.075 mmol) and stirred for 0.5 h at room temp-
erature and then added to a suspension of N-iodosuccinimide
(0.11 g, 0.50 mmol) in toluene (0.5 mL). 4-Aminobenzonitrile
(1a) (0.059 g, 0.50 mmol) was added and the mixture was
stirred at 70 °C for 5 h. Upon completion of the iodination
step, the reaction mixture was cooled to room temperature and
pyrazole (0.10 g, 1.5 mmol), copper(I) iodide (0.0095 g,
0.050 mmol), caesium carbonate (0.33 g, 1.0 mmol), trans-N,
N′-dimethylcyclohexane-1,2-diamine (6) (16 µL, 0.10 mmol)
and water (0.25 mL) were added. The reaction mixture was
degassed under argon for 0.1 h and then heated to 130 °C for
24 h. The reaction mixture was cooled to room temperature,
diluted with ethyl acetate (10 mL), washed with a 1 M aqueous
sodium thiosulfate solution (10 mL). The aqueous layer was
extracted with ethyl acetate (3 × 10 mL) and the combined
organic layers were washed with brine (10 mL). The organic
phase was dried (MgSO4), filtered and concentrated in vacuo.
Purification by flash column chromatography (petroleum
ether/ethyl acetate, 7 : 3) gave N-(2-amino-5-cyanophenyl)-1H-
pyrazole (3a) (0.055 g, 60%) as a colourless oil. Spectroscopic
data were consistent with the literature.26 δH (500 MHz, CDCl3)
5.45 (2H, br s, NH2), 6.50 (1H, t, J 2.2 Hz, 4′-H), 6.81 (1H, d,
J 8.4 Hz, 3-H), 7.39 (1H, dd, J 8.4, 1.9 Hz, 4-H), 7.47 (1H, d,
J 1.9 Hz, 6-H), 7.75 (1H, d, J 2.2 Hz, ArH), 7.77 (1H, d, J 2.2 Hz,
ArH); δC (126 MHz, CDCl3) 99.7 (C), 107.2 (CH), 117.0 (CH),
119.2 (C), 125.5 (C), 127.3 (CH), 129.7 (CH), 132.2 (CH), 141.2
(CH), 145.0 (C); m/z (ESI) 207 (MNa+. 100%).
N-(2-Amino-5-nitrophenyl)-1H-pyrazole (3b)
N-(2-Amino-5-nitrophenyl)-1H-pyrazole (3b) was synthesised as
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-nitroaniline (1b) (0.070 g, 0.50 mmol) and pyrazole
(0.10 g, 1.5 mmol). The iodination step was carried out at
70 °C for 5 h and the N-arylation step at 130 °C for 24 h.
Purification by flash column chromatography (petroleum
ether/ethyl acetate, 4 : 1) gave N-(2-amino-5-nitrophenyl)-1H-
pyrazole (3b) (0.073 g, 71%) as a yellow solid. Mp 137–139 °C;
νmax/cm
−1 (neat) 3319 (NH), 3080 (CH), 1633, 1614, 1527
(CvC), 1494, 1333, 1316, 707; δH (500 MHz, CDCl3) 5.84 (2H,
br s, NH2), 6.52 (1H, t, J 2.0 Hz, 4′-H), 6.80 (1H, d, J 8.9 Hz,
3-H), 7.78 (1H, d, J 2.0 Hz, ArH), 7.86 (1H, d, J 2.0 Hz, ArH),
8.05 (1H, dd, J 8.9, 2.5 Hz, 4-H), 8.17 (1H, d, J 2.5 Hz, 6-H);
δC (126 MHz, CDCl3) 107.4 (CH), 115.8 (CH), 119.4 (CH), 124.2
(C), 124.4 (CH), 129.8 (CH), 138.1 (C), 141.2 (CH), 146.8 (C);
m/z (EI) 204.0654 (M+. C9H8N4O2 requires 204.0647), 174
(20%), 159 (19), 149 (20), 131 (15), 83 (100), 77 (23), 69 (28),
57 (46).
3-Pyrazol-1′-yl-4-aminobenzophenone (3c)
3-Pyrazol-1′-yl-4-aminobenzophenone (3c) was synthesised as
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-aminobenzophenone (1c) (0.059 g, 0.50 mmol) and
pyrazole (0.10 g, 1.5 mmol). The iodination step was carried
out at 70 °C for 20 h and the N-arylation step at 130 °C for
24 h. Purification by flash column chromatography (dichloro-
methane/petroleum ether, 9 : 1 to dichloromethane/petroleum
ether, 4 : 1) gave 3-pyrazol-1′-yl-4-aminobenzophenone (3c)
(0.076 g, 64%) as a colourless oil. νmax/cm
−1 (neat) 3360 (NH),
1611 (CvO), 1518, 1396, 1269, 1148; δH (500 MHz, CDCl3) 5.44
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(2H, br s, NH2), 6.47 (1H, t, J 2.2 Hz, 4′-H), 6.82 (1H, d,
J 8.4 Hz, 5-H), 7.44–7.50 (2H, m, 3″-H and 5″-H), 7.56 (1H, tt,
J 7.4, 1.3 Hz, 4″-H), 7.65 (1H, dd, J 8.4, 1.9 Hz, 6-H), 7.72–7.77
(3H, m, 2-H, 2″-H and 6″-H), 7.79 (1H, d, J 2.2 Hz, ArH), 7.81
(1H, d, J 2.2 Hz, ArH); δC (126 MHz, CDCl3) 106.8 (CH), 115.9
(CH), 125.3 (C), 126.1 (CH), 126.9 (C), 128.3 (2 × CH), 129.5
(2 × CH), 129.9 (CH), 131.5 (CH), 131.7 (CH), 138.4 (C), 140.8
(CH), 145.3 (C), 194.6 (C); m/z (ESI) 286.0944 (MNa+.
C16H13N3NaO requires 286.0951).
N-(2-Amino-5-chlorophenyl)-1H-pyrazole (3d)26
N-(2-Amino-5-chlorophenyl)-1H-pyrazole (3d) was synthesised
as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-chloroaniline (1d) (0.064 g, 0.50 mmol) and pyrazole
(0.10 g, 1.5 mmol). The iodination step was carried out at
70 °C for 5 h and the N-arylation step at 130 °C for 24 h.
Purification by flash column chromatography (dichloro-
methane) gave N-(2-amino-5-chlorophenyl)-1H-pyrazole (3d)
(0.061 g, 63%) as a brown oil. Spectroscopic data were consist-
ent with the literature.26 δH (500 MHz, CDCl3) 4.75 (2H, br s,
NH2), 6.44 (1H, t, J 2.2 Hz, 4′-H), 6.74 (1H, d, J 8.5 Hz, 3-H),
7.08 (1H, dd, J 8.5, 2.4 Hz, 4-H), 7.18 (1H, d, J 2.4 Hz, 6-H),
7.70 (1H, d, J 2.2 Hz, ArH), 7.73 (1H, d, J 2.2 Hz, ArH);
δC (126 MHz, CDCl3) 106.8 (CH), 118.2 (CH), 122.2 (C), 123.7
(CH), 126.8 (C), 128.2 (CH), 129.8 (CH), 139.7 (C), 140.9 (CH);
m/z (ESI) 216 (MNa+. 100%).
N-(2-Amino-5-methylphenyl)-1H-pyrazole (3e)26
N-(2-Amino-5-methylphenyl)-1H-pyrazole (3e) was synthesised
as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-methylaniline (1e) (0.054 g, 0.50 mmol) and pyrazole
(0.10 g, 1.5 mmol). The iodination step was carried out at
40 °C for 5 h and the N-arylation step at 130 °C for 24 h.
Purification by flash column chromatography (petroleum
ether/ethyl acetate, 7 : 3) gave N-(2-amino-5-methylphenyl)-1H-
pyrazole (3e) (0.051 g, 58%) as an orange oil. Spectroscopic
data were consistent with the literature.26 δH (400 MHz, CDCl3)
2.27 (3H, s, 5-CH3), 4.48 (2H, br s, NH2), 6.42 (1H, t, J 2.1 Hz,
4′-H), 6.74 (1H, d, J 8.1 Hz, 3-H), 6.96 (1H, dd, J 8.1, 1.3 Hz,
4-H), 7.00 (1H, d, J 1.3 Hz, 6-H), 7.70 (1H, d, J 2.1 Hz, ArH),
7.73 (1H, d, J 2.1 Hz, ArH); δC (101 MHz, CDCl3) 20.3 (CH3),
106.3 (CH), 117.4 (CH), 124.7 (CH), 126.6 (C), 127.6 (C), 129.1
(CH), 129.8 (CH), 138.5 (C), 140.5 (CH); m/z (ESI) 174 (MNa+.
100%).
N-(2-Methoxy-5-methylphenyl)-1H-pyrazole (3f)
N-(2-Methoxy-5-methylphenyl)-1H-pyrazole (3f ) was syn-
thesised as described for N-(2-amino-5-cyanophenyl)-1H-pyra-
zole (3a) using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol)
and pyrazole (0.10 g, 1.5 mmol). The iodination step was
carried out at 70 °C for 20 h and the N-arylation step at 130 °C
for 24 h. Purification by flash column chromatography
(hexane/diethyl ether, 4 : 1) gave N-(2-methoxy-5-methyl-
phenyl)-1H-pyrazole (3f ) (0.067 g, 71%) as a colourless oil.
νmax/cm
−1 (neat) 2936 (CH), 1524 (CvC), 1504, 1462, 1283,
1242, 1036, 804, 744; δH (400 MHz, CDCl3) 2.33 (3H, br s,
5-CH3), 3.83 (3H, s, OCH3), 6.41 (1H, dd, J 2.4, 1.9 Hz, 4′-H),
6.92 (1H, d, J 8.4 Hz, 3-H), 7.05–7.10 (1H, m, 4-H), 7.55 (1H, d,
J 2.3 Hz, 6-H), 7.69 (1H, dd, J 2.4, 0.4 Hz, ArH), 8.03 (1H, dd,
J 1.9, 0.4 Hz, ArH); δC (101 MHz, CDCl3) 20.4 (CH3), 56.1 (CH3),
106.1 (CH), 112.3 (CH), 125.6 (CH), 128.3 (CH), 129.4 (C), 130.8
(C), 131.5 (CH), 139.9 (CH), 149.1 (C); m/z (EI) 188.0942
(M+. C11H12N2O requires 188.0950), 159 (55%), 144 (34).
N-(2-Methoxy-4,5-dimethylphenyl)-1H-pyrazole (3g)
N-(2-Methoxy-4,5-dimethylphenyl)-1H-pyrazole (3g) was syn-
thesised as described for N-(2-amino-5-cyanophenyl)-1H-pyra-
zole (3a) using 3,4-dimethylanisole (1g) (0.070 mL, 0.50 mmol)
and pyrazole (0.10 g, 1.5 mmol). The iodination step was
carried out at 70 °C for 5 h and the N-arylation step at 130 °C
for 24 h. Purification by flash column chromatography
(hexane/diethyl ether, 9 : 1) gave N-(2-methoxy-4,5-dimethyl-
phenyl)-1H-pyrazole (3g) (0.068 g, 67%) as a colourless oil.
νmax/cm
−1 (neat) 2932 (CH), 1520, 1466, 1396, 1242, 1188,
1034, 748; δH (400 MHz, CDCl3) 2.23 (3H, s, CH3), 2.29 (3H, s,
CH3), 3.82 (3H, s, OCH3), 6.39 (1H, dd, J 2.3, 1.7 Hz, 4′-H), 6.81
(1H, s, 3-H), 7.47 (1H, s, 6-H), 7.67 (1H, d, J 1.7 Hz, ArH), 7.97
(1H, d, J 2.3 Hz, ArH); δC (101 MHz, CDCl3) 18.7 (CH3), 19.9
(CH3), 56.1 (CH3), 105.9 (CH), 113.9 (CH), 126.1 (CH), 127.2
(C), 129.2 (C), 131.4 (CH), 136.4 (C), 139.7 (CH), 149.1 (C); m/z
(ESI) 225.0994 (MNa+. C12H14N2NaO requires 225.0998).
3-Pyrazol-1′-yl-4-methoxybiphenyl (3h)
3-Pyrazol-1′-yl-4-methoxybiphenyl (3h) was synthesised as
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-methoxybiphenyl (1h) (0.050 g, 0.19 mmol) and pyra-
zole (0.051 g, 0.75 mmol). The iodination step was carried out
at 70 °C for 5 h and the N-arylation step at 130 °C for 24 h.
Purification by flash column chromatography (hexane/diethyl
ether, 7 : 3) gave 3-pyrazol-1′-yl-4-methoxybiphenyl (3h)
(0.077 g, 61%) as a white solid. Mp 52–54 °C; νmax/cm
−1 (neat)
2940 (CH), 1528 (CvC), 1489, 1404, 1281, 1250, 1018, 756;
δH (500 MHz, CDCl3) 3.92 (3H, s, OCH3), 6.45 (1H, dd, J 2.3,
1.8 Hz, 4′-H), 7.11 (1H, d, J 8.6 Hz, 5-H), 7.32 (1H, tt, J 7.4,
1.2 Hz, 4″-H), 7.38–7.44 (2H, m, 3″-H and 5″-H), 7.52 (1H, dd,
J 8.6, 2.4 Hz, 6-H), 7.58–7.63 (2H, m, 2″-H and 6″-H), 7.73 (1H,
d, J 1.8 Hz, ArH), 7.99 (1H, d, J 2.4 Hz, 2-H), 8.08 (1H, d,
J 2.3 Hz, ArH); δC (126 MHz, CDCl3) 56.1 (CH3), 106.3 (CH),
112.7 (CH), 123.9 (CH), 126.3 (CH), 126.8 (2 × CH), 127.1 (CH),
128.8 (2 × CH), 129.9 (C), 131.6 (CH), 134.5 (C), 139.8 (C), 140.2
(CH), 150.7 (C); m/z (ESI) 273.0992 (MNa+. C16H14N2NaO
requires 273.0998).
N-(2,5-Dimethoxyphenyl)-1H-pyrazole (3i)
N-(2,5-Dimethoxyphenyl)-1H-pyrazole (3i) was synthesised as
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 1,4-dimethoxybenzene (1i) (0.069 g, 0.50 mmol) and pyr-
azole (0.10 g, 1.5 mmol). The iodination step was carried out
at 70 °C for 5 h and the N-arylation step at 150 °C for 24 h.
Purification by flash column chromatography (petroleum
ether/ethyl acetate, 9 : 1) gave N-(2,5-dimethoxyphenyl)-1H-pyr-
azole (3i) (0.067 g, 66%) as a colourless oil. νmax/cm
−1 (neat)
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2940 (CH), 1597, 1520, 1504, 1211, 1042, 748; δH (400 MHz,
CDCl3) 3.82 (6H, br s, 2 × OCH3), 6.42 (1H, dd, J 2.4, 1.9 Hz, 4′-
H), 6.83 (1H, dd, J 9.0, 3.1 Hz, 4-H), 6.98 (1H, d, J 9.0 Hz, 3-H),
7.36 (1H, d, J 3.1 Hz, 6-H), 7.70 (1H, d, J 1.9 Hz, ArH), 8.10 (1H,
d, J 2.4 Hz, ArH); δC (101 MHz, CDCl3) 55.9 (CH3), 56.7 (CH3),
106.3 (CH), 110.0 (CH), 113.6 (CH), 114.0 (CH), 130.2 (C), 131.6
(CH), 140.1 (CH), 145.1 (C), 154.1 (C); m/z (ESI) 227.0785
(MNa+. C11H12N2NaO2 requires 227.0791).
2″-(4-Methoxy-3-pyrazol-1′-ylphenyl)acetic acid (3j)
2″-(4-Methoxy-3-pyrazol-1′-ylphenyl)acetic acid (3j) was syn-
thesised as described for N-(2-amino-5-cyanophenyl)-1H-pyra-
zole (3a) using 4-methoxyphenylacetic acid (1j) (0.083 g,
0.50 mmol) and pyrazole (0.10 g, 1.5 mmol). The iodination
step was carried out at 70 °C for 5 h and the N-arylation step at
150 °C for 24 h. The reaction mixture was cooled to room
temperature, diluted with dichloromethane (10 mL) and
extracted with 1 M aqueous sodium hydroxide solution
(10 mL). The aqueous layer was separated and acidified with
1 M aqueous hydrochloric acid and extracted into dichloro-
methane (3 × 30 mL). The combined organic layers were dried
(MgSO4) and concentrated in vacuo. Trituration with hexane
gave 2″-(4-methoxy-3-pyrazol-1′-ylphenyl)acetic acid (3j)
(0.062 g, 53%) as a white solid. Mp 94–96 °C; νmax/cm
−1 (neat)
2940 (CH), 1713 (CvO), 1526 (CvC), 1462, 1410, 1287, 1248,
1180, 1152, 1022, 760; δH (400 MHz, CDCl3) 3.62 (2H, s, CH2),
3.86 (3H, s, OCH3), 6.42 (1H, dd, J 2.3, 1.8 Hz, 4′-H), 6.99 (1H,
d, J 8.5 Hz, 5-H), 7.21 (1H, dd, J 8.5, 2.1 Hz, 6-H), 7.67 (1H, d,
J 2.1 Hz, 2-H), 7.73 (1H, d, J 1.8 Hz, ArH), 8.02 (1H, d, J 2.3 Hz,
ArH); δC (101 MHz, CDCl3) 40.1 (CH2), 56.0 (CH3), 106.3 (CH),
112.4 (CH), 126.4 (CH), 126.9 (C), 129.1 (CH), 129.2 (C), 131.9
(CH), 139.9 (CH), 150.2 (C), 175.5 (C); m/z (ESI) 255.0738
(MNa+. C12H12N2NaO3 requires 255.0740).
N-(5-Acetyl-2,4-dimethoxyphenyl)-1H-pyrazole (3k)
N-(5-Acetyl-2,4-dimethoxyphenyl)-1H-pyrazole (3k) was syn-
thesised as described for N-(2-amino-5-cyanophenyl)-1H-pyra-
zole (3a) using 2,4-dimethoxyacetophenone (1k) (0.090 g,
0.50 mmol) and pyrazole (0.10 g, 1.5 mmol). The iodination
step was carried out at 70 °C for 5 h and the N-arylation step at
150 °C for 24 h. Purification by flash column chromatography
(petroleum ether/ethyl acetate, 4 : 1) followed by trituration
with diethyl ether gave N-(5-acetyl-2,4-dimethoxyphenyl)-1H-
pyrazole (3k) (0.059 g, 48%) as a white solid. Mp 122–124 °C;
νmax/cm
−1 (neat) 2931 (CH), 1659 (CvO), 1605, 1520, 1265,
1227, 1026, 741; δH (500 MHz, CDCl3) 2.60 (3H, s, COMe), 3.93
(3H, s, OCH3), 3.99 (3H, s, OCH3), 6.41 (1H, dd, J 2.3, 1.8 Hz,
4′-H), 6.57 (1H, s, 3-H), 7.69 (1H, d, J 1.8 Hz, ArH), 7.78 (1H, d,
J 2.3 Hz, ArH), 8.08 (1H, s, 6-H); δC (126 MHz, CDCl3) 31.7
(CH3), 56.0 (CH3), 56.2 (CH3), 95.8 (CH), 106.1 (CH), 120.6 (C),
123.4 (C), 128.8 (CH), 131.3 (CH), 140.2 (CH), 156.7 (C), 159.9
(C), 196.8 (C); m/z (ESI) 269.0889 (MNa+. C13H14N2NaO3
requires 269.0897).
N-(2-Hydroxy-5-methylphenyl)-1H-pyrazole (3l)
An oven-dried microwave vial was flushed with argon and
charged with N-iodosuccinimide (0.11 g, 0.50 mmol) and dry
toluene (3 mL). To this suspension was added silver bis(tri-
fluoromethanesulfonyl)imide (0.015 g, 0.038 mmol) and
p-cresol (1l) (0.053 mL, 0.50 mmol). The reaction mixture was
stirred at 40 °C for 5 h in the dark. The reaction mixture was
cooled to room temperature and pyrazole (0.10 g, 1.5 mmol),
copper(I) iodide (0.0095 g, 0.050 mmol), caesium carbonate
(0.33 g, 1.0 mmol), trans-N,N′-dimethylcyclohexane-1,2-
diamine (6) (0.16 µL, 0.10 mmol) and water (0.5 mL) were
added. The reaction mixture was degassed under argon for
0.1 h and then heated to 130 °C for 24 h. The reaction mixture
was then cooled to room temperature, diluted with ethyl
acetate (10 mL), washed with a 1 M aqueous sodium thiosul-
fate solution (10 mL). The aqueous layer was extracted with
ethyl acetate (3 × 10 mL) and the combined organic layers were
washed with brine (10 mL). The organic phase was dried
(MgSO4), filtered and concentrated in vacuo. Purification by
flash column chromatography (hexane/diethyl ether, 4 : 1) gave
N-(2-hydroxy-5-methylphenyl)-1H-pyrazole (3l) (0.032 g, 37%)
as a colourless oil. νmax/cm
−1 (neat) 3036 (OH), 2920 (CH),
1518 (CvC), 1333, 1279, 1250, 750; δH (400 MHz, CDCl3) 2.33
(3H, s, 5-CH3), 6.49 (1H, dd, J 2.4, 2.1 Hz, 4′-H), 6.95–7.01 (2H,
m, 3-H and 4-H), 7.18 (1H, br s, 6-H), 7.72 (1H, d, J 2.1 Hz,
ArH), 7.99 (1H, d, J 2.4 Hz, ArH), 11.11 (1H, s, OH);
δC (101 MHz, CDCl3) 20.6 (CH3), 106.7 (CH), 118.3 (CH), 118.7
(CH), 124.5 (C), 126.6 (CH), 128.2 (CH), 128.9 (C), 138.9 (CH),
147.0 (C); m/z (ESI) 197.0684 (MNa+. C10H10N2NaO requires
197.0685).
N-(2-Methoxy-5-methylphenyl)benzenesulfonamide (3m)
N-(2-Methoxy-5-methylphenyl)benzenesulfonamide (3m) was
synthesised as described for N-(2-amino-5-cyanophenyl)-1H-
pyrazole (3a) using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol)
and benzenesulfonamide (0.24 g, 1.5 mmol). The iodination
step was carried out at 70 °C for 5 h and the N-arylation step at
150 °C for 24 h. Purification by flash column chromatography
(hexane/diethyl ether, 1 : 1) gave N-(2-methoxy-5-methylphenyl)
benzenesulfonamide (3m) (0.084 g, 61%) as a white solid.
Mp 134–136 °C; νmax/cm
−1 (neat) 3011 (CH), 1506, 1389, 1327,
1256, 1165, 1090, 1030, 907, 727; δH (400 MHz, CDCl3) 2.25
(3H, s, 5-CH3), 3.54 (3H, s, OCH3), 6.59 (1H, d, J 8.3 Hz, 3-H),
6.82 (1H, dd, J 8.3, 1.6 Hz, 4-H), 6.98 (1H, br s, NH), 7.34 (1H,
d, J 1.6 Hz, 6-H), 7.36–7.43 (2H, m, 3′-H and 5′-H), 7.48 (1H, t,
J 7.4 Hz, 4′-H), 7.71–7.77 (2H, m, 2′-H and 6′-H); δC (101 MHz,
CDCl3) 20.7 (CH3), 55.7 (CH3), 110.5 (CH), 122.4 (CH), 125.4
(C), 125.9 (CH), 127.2 (2 × CH), 128.7 (2 × CH), 130.6 (C), 132.8
(CH), 139.2 (C), 147.7 (C); m/z (ESI) 300.0653 (MNa+.
C14H15NNaO3S requires 300.0665).
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzenesulfonamide
(3n)
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzenesulfonamide
(3n) was synthesised as described for N-(2-amino-5-cyano-
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phenyl)-1H-pyrazole (3a) using 4-methylanisole (1f ) (0.063 mL,
0.50 mmol) and p-toluenesulfonamide (0.26 g, 1.5 mmol). The
iodination step was carried out at 70 °C for 5 h and the
N-arylation step at 150 °C for 24 h. Purification by flash
column chromatography (hexane/diethyl ether, 1 : 1) gave
N-(2-methoxy-5-methylphenyl)-4′-methylbenzenesulfonamide
(3n) (0.113 g, 78%) as a white solid. Mp 68–70 °C; νmax/cm
−1
(neat) 3400 (NH), 2936 (CH), 1595 (CvC), 1508, 1389, 1330,
1252, 1163, 1123, 1090, 808; δH (400 MHz, CDCl3) 2.25 (3H, s,
4′-CH3), 2.35 (3H, s, 5-CH3), 3.58 (3H, s, OCH3), 6.60 (1H, d,
J 8.4 Hz, 3-H), 6.81 (1H, dd, J 8.4, 2.1 Hz, 4-H), 6.95 (1H, br s,
NH), 7.18 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.34 (1H, d, J 2.1 Hz,
6-H), 7.63 (2H, d, J 8.2 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3)
20.8 (CH3), 21.5 (CH3), 55.7 (CH3), 110.5 (CH), 121.8 (CH),
125.6 (CH), 125.7 (C), 127.2 (2 × CH), 129.3 (2 × CH), 130.6 (C),
136.4 (C), 143.5 (C), 147.5 (C); m/z (ESI) 314.0809 (MNa+.
C15H17NNaO3S requires 314.0821).
N-(2-Methoxy-5-methylphenyl)-4′-chlorobenzenesulfonamide
(3o)
N-(2-Methoxy-5-methylphenyl)-4′-chlorobenzenesulfonamide
(3o) was synthesised as described for N-(2-amino-5-cyano-
phenyl)-1H-pyrazole (3a) using 4-methylanisole (1f ) (0.063 mL,
0.50 mmol) and p-chlorobenzenesulfonamide (0.29 g,
1.5 mmol). The iodination step was carried out at 70 °C for 5 h
and the N-arylation step at 150 °C for 24 h. Purification by
flash column chromatography (hexane/diethyl ether, 1 : 1) gave
N-(2-methoxy-5-methylphenyl)-4′-chlorobenzenesulfonamide
(3o) (0.089 g, 55%) as a yellow oil. νmax/cm
−1 (neat) 3273 (NH),
2932 (CH), 1585 (CvC), 1508, 1335, 1252, 1165, 1123, 1086,
752; δH (400 MHz, CDCl3) 2.27 (3H, s, 5-CH3), 3.58 (3H, s,
OCH3), 6.61 (1H, d, J 8.3 Hz, 3-H), 6.85 (1H, dd, J 8.3, 2.0 Hz,
4-H), 6.97 (1H, br s, NH), 7.32–7.38 (3H, m, 6-H, 3′-H and 5′-
H), 7.67 (2H, d, J 8.9 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3)
20.7 (CH3), 55.7 (CH3), 110.5 (CH), 122.6 (CH), 125.0 (C), 126.3
(CH), 128.7 (2 × CH), 129.0 (2 × CH), 130.7 (C), 137.7 (C), 139.2
(C), 147.8 (C); m/z (ESI) 334.0265 (MNa+. C14H14
35ClNNaO3S
requires 334.0275).
N-(2-Methoxy-5-methylphenyl)methanesulfonamide (3p)
N-(2-Methoxy-5-methylphenyl)methanesulfonamide (3p) was
synthesised as described for N-(2-amino-5-cyanophenyl)-1H-
pyrazole (3a) using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol)
and methanesulfonamide (0.14 g, 1.5 mmol). The iodination
step was carried out at 70 °C for 5 h and the N-arylation step at
150 °C for 24 h. Purification by flash column chromatography
(petroleum ether/ethyl acetate, 7 : 3) gave N-(2-methoxy-5-
methylphenyl)methanesulfonamide (3p) (0.061 g, 57%) as a
colourless oil. νmax/cm
−1 (neat) 3267 (NH), 2934 (CH), 1508
(CvC), 1387, 1323, 1252, 1161, 1121, 1028, 970, 760;
δH (500 MHz, CDCl3) 2.30 (3H, s, 5-CH3), 2.94 (3H, s, SO2CH3),
3.85 (3H, s, OCH3), 6.74 (1H, br s, NH), 6.80 (1H, d, J 8.3 Hz,
3-H), 6.92 (1H, dd, J 8.3, 1.9 Hz, 4-H), 7.33 (1H, d, J 1.9 Hz, 6-H);
δC (126 MHz, CDCl3) 20.8 (CH3), 39.0 (CH3), 55.9 (CH3), 110.6
(CH), 121.7 (CH), 125.7 (C), 125.9 (CH), 131.0 (C), 147.5 (C); m/z
(ESI) 238.0502 (MNa+. C9H13NNaO3S requires 238.0508).
N-(2-Methoxy-5-methylphenyl)benzamide (3q)27
N-(2-Methoxy-5-methylphenyl)benzamide (3q) was synthesised
as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol) and benz-
amide (0.18 g, 1.5 mmol). The iodination step was carried out
at 70 °C for 5 h and the N-arylation step at 150 °C for 24 h.
Purification by flash column chromatography (hexane/diethyl
ether, 4 : 1) gave N-(2-methoxy-5-methylphenyl)benzamide (3q)
(0.091 g, 75%) as a colourless oil. Spectroscopic data were con-
sistent with the literature.27 δH (500 MHz, CDCl3) 2.33 (3H, s,
5-CH3), 3.87 (3H, s, OCH3), 6.78 (1H, d, J 8.3 Hz, 3-H), 6.86
(1H, dd, J 8.3 Hz, 2.1 Hz, 4-H), 7.44–7.55 (3H, m, 3′-H, 4′-H and
5′-H), 7.86–7.90 (2H, m, 2′-H and 6′-H), 8.38 (1H, d, J 2.1 Hz,
6-H), 8.52 (1H, br s, NH); δC (126 MHz, CDCl3) 21.0 (CH3), 55.9
(CH3), 109.8 (CH), 120.5 (CH), 124.1 (CH), 127.0 (2 × CH),
127.5 (C), 128.7 (2 × CH), 130.6 (C), 131.6 (CH), 135.3 (C), 146.1
(C), 165.1 (C); m/z (ESI) 264 (MNa+. 100%).
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzamide (3r)
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzamide (3r) was
synthesised as described for N-(2-amino-5-cyanophenyl)-1H-
pyrazole (3a) using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol)
and p-toluamide (0.10 g, 1.5 mmol). The iodination step was
carried out at 70 °C for 5 h and the N-arylation step at 150 °C
for 24 h. Purification by flash column chromatography
(hexane/diethyl ether, 4 : 1) gave N-(2-methoxy-5-methyl-
phenyl)-4′-methylbenzamide (3r) (0.098 g, 77%) as a white
solid. Mp 56–58 °C; νmax/cm
−1 (neat) 3429 (NH), 2920 (CH),
1670 (CvO), 1530 (CvC), 1477, 1423, 1248, 1223, 1138, 1030,
799; δH (400 MHz, CDCl3) 2.33 (3H, s, 5-CH3), 2.41 (3H, s, 4′-
CH3), 3.87 (3H, s, OCH3), 6.78 (1H, d, J 8.2 Hz, 3-H), 6.85 (1H,
dd, J 8.2, 2.0 Hz, 4-H), 7.27 (2H, d, J 8.1 Hz, 3′-H and 5′-H),
7.78 (2H, d, J 8.1 Hz, 2′-H and 6′-H), 8.38 (1H, d, J 2.0 Hz, 6-H),
8.50 (1H, br s, NH); δC (101 MHz, CDCl3) 21.0 (CH3), 21.5
(CH3), 55.9 (CH3), 109.8 (CH), 120.4 (CH), 123.9 (CH), 127.0 (2
× CH), 127.6 (C), 129.4 (2 × CH), 130.6 (C), 132.5 (C), 142.1 (C),
146.1 (C), 165.1 (C); m/z (ESI) 278.1146 (MNa+. C16H17NNaO2
requires 278.1151).
N-(2-Methoxy-5-methylphenyl)pyrrolidin-2′-one (3s)28
N-(2-Methoxy-5-methylphenyl)pyrrolidin-2′-one (3s) was syn-
thesised as described for N-(2-amino-5-nitrophenyl)-1H-pyra-
zole (3a) using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol)
and pyrrolidin-2-one (0.11 mL, 1.5 mmol). The iodination step
was carried out at 70 °C for 5 h and the N-arylation step at
150 °C for 24 h. Purification by flash column chromatography
(ethyl acetate) gave N-(2-methoxy-5-methylphenyl)pyrrolidin-2′-
one (3s) (0.053 g, 52%) as a colourless oil. Spectroscopic data
were consistent with the literature.28 δH (500 MHz, CDCl3)
2.12–2.20 (2H, m, 4′-H2), 2.28 (3H, s, 5-CH3), 2.54 (2H, t,
J 7.8 Hz, 3′-H2) 3.73 (2H, t, J 7.0 Hz, 5′-H2), 3.79 (3H, s, OCH3),
6.84 (1H, d, J 8.9 Hz, 3-H), 7.04–7.07 (2H, m, 4-H and 6-H);
δC (126 MHz, CDCl3) 18.9 (CH2), 20.4 (CH3), 31.2 (CH2), 50.0
(CH2), 55.8 (CH3), 112.1 (CH), 126.9 (C), 129.1 (CH), 129.2
Paper Organic & Biomolecular Chemistry
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(CH), 130.4 (C), 152.7 (C), 175.2 (C); m/z (ESI) 228 (MNa+.
100%).
N-(2-Methoxy-5-methylphenyl)imidazole (3t)29
N-(2-Methoxy-5-methylphenyl)imidazole (3t) was synthesised
as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (3a)
using 4-methylanisole (1f ) (0.063 mL, 0.50 mmol) and imid-
azole (0.10 g, 1.5 mmol). The iodination step was carried out
at 70 °C for 5 h and the N-arylation step at 150 °C for 36 h.
Purification by flash column chromatography (ethyl acetate/
methanol, 9 : 1) gave N-(2-methoxy-5-methylphenyl)imidazole
(3t) (0.049 g, 51%) as a colourless oil. Spectroscopic data were
consistent with the literature.29 δH (500 MHz, CDCl3) 2.33 (3H,
s, 5-CH3), 3.80 (3H, s, OCH3), 6.94 (1H, d, J 8.4 Hz, 3-H), 7.09
(1H, d, J 1.8 Hz, 6-H), 7.14 (1H, dd, J 8.4, 1.8 Hz, 4-H),
7.15–7.24 (2H, m, 5′-H and 4′-H), 7.79 (1H, br s, 2′-H);
δC (126 MHz, CDCl3) 20.4 (CH3), 55.9 (CH3), 112.4 (CH), 120.3
(CH), 126.1 (CH), 126.2 (C), 128.7 (CH), 129.2 (CH), 130.7 (C),
137.8 (CH), 150.4 (C); m/z (ESI) 189 (MH+. 100%).
N-(2-Methoxy-5-methylphenyl)pyrrole (3u)
N-(2-Methoxy-5-methylphenyl)pyrrole (3u) was synthesised as
described for N-(2-amino-5-nitrophenyl)-1H-pyrazole (3a) using
4-methylanisole (1f ) (0.063 mL, 0.50 mmol) and pyrrole
(0.10 mL, 1.5 mmol). The iodination step was carried out at
70 °C for 5 h and the N-arylation step at 150 °C for 36 h.
Purification by flash column chromatography (hexane/diethyl
ether, 9 : 1) gave N-(2-methoxy-5-methylphenyl)pyrrole (3u)
(0.035 g, 37%) as a colourless oil. νmax/cm
−1 (neat) 2931 (CH),
1512 (CvC), 1483, 1327, 1242, 1070, 1024, 723; δH (400 MHz,
CDCl3) 2.32 (3H, s, 5-CH3), 3.79 (3H, s, OCH3), 6.30 (2H, t,
J 2.2 Hz, 3′-H and 4′-H), 6.91 (1H, d, J 8.2 Hz, 3-H), 6.97 (2H, t,
J 2.2 Hz, 2′-H and 5′-H), 7.05 (1H, dd, J 8.2, 2.1 Hz, 4-H), 7.10
(1H, d, J 2.1 Hz, 6-H); δC (101 MHz, CDCl3) 20.4 (CH3), 56.0
(CH3), 108.7 (2 × CH), 112.4 (CH), 122.0 (2 × CH), 126.4 (CH),
127.7 (CH), 130.0 (C), 130.5 (C), 150.6 (C); m/z (ESI) 210.0892
(MNa+. C12H13NNaO requires 210.0889).
N-Methyl-6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16a)
N-Methyl-6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16a) was synthesised as described for N-(2-
amino-5-cyanophenyl)-1H-pyrazole (3a) using N-methyl-7-
methoxy-3,4-dihydro-1H-quinolin-2-one (14) (0.0500 g,
0.262 mmol), benzenesulfonamide (0.122 g, 0.780 mmol), iron
(III) chloride (1.01 mg, 0.00625 mmol) and [BMIM]NTf2
(6.00 μL, 0.0196 mmol). The iodination step was carried out at
40 °C for 4 h and the N-arylation step at 150 °C for 20 h.
Purification by flash column chromatography (ethyl acetate/
hexane, 7 : 3) gave N-methyl-6-benzenesulfonamide-7-methoxy-
3,4-dihydro-1H-quinolin-2-one (16a) (0.0510 g, 56%) as a white
solid. Mp 185–188 °C; νmax/cm
−1 (neat) 3252 (NH), 2967 (CH),
1665 (CvO), 1616, 1518, 1332, 1171, 1146, 1115, 1092, 1061,
934, 763; δH (400 MHz, CDCl3) 2.61 (2H, dd, J 9.2, 6.8 Hz,
4-H2), 2.83 (2H, dd, J 7.6, 6.8 Hz, 3-H2), 3.29 (3H, s, NCH3),
3.55 (3H, s, OCH3), 6.33 (1H, s, 8-H), 6.76 (1H, br s, NH), 7.35
(1H, s, 5-H), 7.39–7.44 (2H, m, 3′-H and 5′-H), 7.52 (1H, tt,
J 7.2, 1.2 Hz, 4′-H), 7.70–7.74 (2H, m, 2′-H and 6′-H); δc
(101 MHz, CDCl3) 24.6 (CH2), 29.6 (CH3), 31.8 (CH2), 55.8
(CH3), 98.7 (CH), 118.6 (C), 120.0 (C), 122.5 (CH), 127.2 (2 ×
CH), 128.7 (2 × CH), 132.8 (CH), 138.8 (C), 139.3 (C), 149.8 (C),
170.4 (C); m/z (ESI) 369.0873 (MNa+. C17H18N2NaO4S requires
369.0879).
N-Methyl-6-(p-toluenesulfonamide)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16b)
N-Methyl-6-(p-toluenesulfonamide)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16b) was synthesised as described for N-methyl-
6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(16a) using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(14) (0.0500 g, 0.262 mmol) and p-toluenesulfonamide
(0.134 g, 0.780 mmol). The iodination step was carried out at
40 °C for 4 h and the N-arylation step at 150 °C for 20 h.
Purification by flash column chromatography (ethyl acetate/
hexane, 7 : 3) gave N-methyl-6-(p-toluenesulfonamide)-7-
methoxy-3,4-dihydro-1H-quinolin-2-one (16b) (0.0530 g, 56%)
as a white solid. Mp 162–164 °C; νmax/cm
−1 (neat) 3255
(NH), 2924 (C–H), 1661 (CvO), 1512, 1342, 1150; δH
(400 MHz, CDCl3) 2.38 (3H, s, CH3), 2.61 (2H, dd, J = 9.2,
7.2 Hz, 4-H2), 2.82 (2H, dd, J = 9.2, 6.8 Hz, 3-H2), 3.29 (3H, s,
NCH3), 3.59 (3H, s, OCH3), 6.35 (1H, s, NH), 6.79 (1H, s,
8-H), 7.20 (2H, d, J = 8.5 Hz, 4′-H and 6′-H), 7.34 (1H, s, 5-H),
7.62 (2H, d, J = 8.5 Hz, 3′-H and 7′-H); δC (101 MHz, CDCl3)
21.5 (CH3), 24.6 (CH2), 29.6 (CH3), 31.8 (CH2), 55.9 (CH3),
98.8 (CH), 118.5 (C), 120.3 (C), 122.0 (CH), 127.2 (2 × CH),
129.4 (2 × CH), 136.4 (C), 138.5 (C), 143.6 (C), 149.5 (C),
170.4 (C); m/z (ESI) 383.1022 (MNa+. C18H20N2O4S requires
383.1036).
N-Methyl-6-benzamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(16c)
N-Methyl-6-benzamide-7-methoxy-3,4-dihydro-1H-quinolin-2-
one (16c) was synthesised as described for N-methyl-6-benz-
enesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one (16a)
using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one (14)
(0.0500 g, 0.262 mmol) and benzamide (0.094 g, 0.780 mmol).
The iodination step was carried out at 40 °C for 4 h and the
N-arylation step at 150 °C for 20 h. Purification by flash
column chromatography (dichloromethane/ethyl acetate, 4 : 1)
gave N-methyl-6-benzamide-7-methoxy-3,4-dihydro-1H-quino-
lin-2-one (16c) (0.0480 g, 60%) as a white solid. Mp
168–170 °C; νmax/cm
−1 (neat) 3428 (NH), 2941 (CH), 1661
(CvO), 1530, 1124, 1059; δH (400 MHz, CDCl3) 2.65 (2H, dd,
J = 9.2, 7.2 Hz, 4-H2), 2.89 (2H, dd, J = 9.2, 6.8 Hz, 3-H2), 3.37
(3H, s, NCH3), 3.95 (3H, s, OCH3), 6.57 (1H, s, NH), 7.47–7.59
(3H, m, 4′-H, 5′-H and 6′-H), 7.87–7.91 (2H, m, 3′-H and 7′-H),
8.37 (1H, s, 8-H), 8.42 (1H, s, 5-H); δC (101 MHz, CDCl3) 24.9
(CH2), 29.6 (CH3), 32.0 (CH2), 56.2 (CH3), 98.3 (CH), 118.4
(C), 119.5 (CH), 122.6 (C), 127.0 (2 × CH), 128.8 (2 × CH),
131.8 (CH), 135.1 (C), 136.8 (C), 147.6 (C), 165.1 (C), 170.4
(C); m/z (ESI) 333.1200 (MNa+. C18H18N2O3 requires
333.1210).
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N-Methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16d)
N-Methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16d) was synthesised as described for N-methyl-
6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(16a) using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(14) (0.0500 g, 0.262 mmol) and p-toluamide (0.106 g,
0.783 mmol). The iodination step was carried out at 40 °C for
4 h and the N-arylation step at 150 °C for 20 h. Purification by
flash column chromatography (dichloromethane/diethyl ether,
3 : 2) gave N-methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-
dihydro-1H-quinolin-2-one (16d) (0.0520 g, 61%) as a white
solid. Mp 164–166 °C; νmax/cm
−1 (neat) 3428 (NH), 2955 (CH),
1663 (CvO), 1614, 1533, 1472, 1427, 1350, 1265, 1244, 1206,
1126, 1061, 745; δH (500 MHz, CDCl3) 2.43 (3H, s, 4′-CH3),
2.62–2.66 (2H, m, 4-H2), 2.86–2.90 (2H, m, 3-H2), 3.37 (3H, s,
NCH3), 3.94 (3H, s, OCH3), 6.56 (1H, s, 8-H), 7.29 (2H, d,
J 8.2 Hz, 3′-H and 5′-H), 7.78 (2H, d, J 8.2 Hz, 2′-H and 6′-H),
8.36 (1H, s, 5-H), 8.39 (1H, br s, NH); δc (126 MHz, CDCl3) 21.5
(CH3), 24.9 (CH2), 29.6 (CH3), 32.0 (CH2), 56.2 (CH3), 98.3
(CH), 118.3 (C), 119.4 (CH), 122.7 (C), 127.0 (2 × CH), 129.4
(2 × CH), 132.3 (C), 136.6 (C), 142.3 (C), 147.6 (C), 165.1 (C),
170.5 (C); m/z (ESI) 347.1364 (MNa+. C19H20N2NaO3 requires
347.1366).
N-Methyl-6-(2-pyrrolidinone)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (16e)
N-Methyl-6-(2-pyrrolidinone)-7-methoxy-3,4-dihydro-1H-quino-
lin-2-one (16e) was synthesised as described for N-methyl-6-
benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(16a) using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(14) (0.0500 g, 0.262 mmol) and 2-pyrrolidinone (59.3 μL,
0.780 mmol). The iodination step was carried out at 40 °C for
4 h and the N-arylation step at 150 °C for 72 h. Purification by
flash column chromatography (methanol/ethyl acetate, 1 : 20
to methanol/ethyl acetate, 1 : 10) gave N-methyl-6-(2-pyrrolidi-
none)-7-methoxy-3,4-dihydro-1H-quinolin-2-one (16e) (0.0360 g,
51%) as a white solid. Mp 188–190 °C; νmax/cm
−1 (neat) 2970
(CH), 1667 (CvO), 1612, 1520, 1450, 1420, 1350, 1281, 1057;
δH (400 MHz, CDCl3) 2.15–2.23 (2H, m, 4′-H2), 2.55 (2H, t, J =
8.4 Hz, 5′-H2), 2.64 (2H, dd, J = 9.2, 6.8 Hz, 4-H2), 2.83 (2H, dd,
J = 9.2, 6.8 Hz, 3-H2), 3.36 (3H, s, NCH3), 3.73 (2H, t, J = 7.2 Hz,
3′-H2), 3.86 (3H, s, OCH3), 6.57 (1H, s, 8-H), 7.05 (1H, s, 5-H);
δC (101 MHz, CDCl3) 18.9 (CH2), 24.4 (CH2), 29.7 (CH3), 31.1
(CH2), 31.8 (CH2), 50.0 (CH2), 56.0 (CH3), 100.0 (CH), 118.4 (C),
121.6 (C), 127.6 (CH), 140.8 (C), 154.2 (C), 170.5 (C), 175.4 (C);
m/z (ESI) 297.1214 (MNa+. C15H18N2NaO3 requires 297.1210).
N-Methyl-6-pyrazole-7-methoxy-3,4-dihydro-1H-quinolin-2-one
(16f)
N-Methyl-6-(1H-pyrazole)-7-methoxy-3,4-dihydro-1H-quinolin-2-
one (16f ) was synthesised as described for N-methyl-6-benz-
enesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one (16a)
using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one (14)
(0.0500 g, 0.262 mmol) and pyrazole (0.531 g, 0.780 mmol).
The iodination step was carried out at 40 °C for 4 h and the
N-arylation step at 150 °C for 20 h. Purification by flash
column chromatography (ethyl acetate/hexane, 7 : 3) gave
N-methyl-6-(1H-pyrazole)-7-methoxy-3,4-dihydro-1H-quinolin-2-
one (16f ) (0.0400 g, 60%) as a white solid. Mp 168–170 °C;
νmax/cm
−1 (neat) 2947 (CH), 1667 (CvO), 1620, 1528, 1466,
1350, 1188, 1134, 1034; δH (400 MHz, CDCl3) 2.66 (2H, dd, J =
9.2, 6.8 Hz, 4-H2), 2.89 (2H, dd, J = 9.2, 6.8 Hz, 3-H2), 3.40 (3H,
s, NCH3), 3.89 (3H, s, OCH3), 6.42 (1H, dd, J = 2.3, 1.7 Hz, 4′-
H), 6.65 (1H, s, 8-H), 7.54 (1H, s, 5-H), 7.69 (1H, d, J = 1.7 Hz,
3′-H), 7.99 (1H, d, J = 2.3 Hz, 5′-H); δC (101 MHz, CDCl3) 24.4
(CH2), 29.7 (CH3), 31.8 (CH2), 56.4 (CH3), 100.1 (CH), 106.2
(CH), 118.8 (C), 124.3 (CH), 124.5 (C), 131.4 (CH), 140.0 (CH),
140.2 (C), 150.5 (C), 170.4 (C); m/z (ESI) 280.1052 (MNa+.
C14H15N3NaO2 requires 280.1056).
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